TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04045613 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT00078910 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01908309 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01908309 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02901145 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03225755 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT03225755 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03225755 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT01704781 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00935051 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT00935051 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT03009721 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00621816 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02482753 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02748057 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00320385 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04116502 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03637868 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03092492 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00880373 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00006064 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00766077 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02294539 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03820154 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03612427 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04448054 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06019026 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03612479 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01393418 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04310293 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04537390 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02892123 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04469634 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03804099 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03804099 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02715102 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04638556 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study NCT03736837 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04102930 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT03102749 — Predictive Biomarker (PRD): SCGB1A1 mRNA
Genes: SCGB1A1; CC10; CCSP; UGB
Study NCT03102749 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00642720 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02314377 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02015793 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03176238 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03176238 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03176238 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03176238 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02457351 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00525603 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT00525603 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02102672 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00650143 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01600547 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01666444 — Predictive Biomarker (PRD): TLR8 mRNA
Genes: TLR8; UNQ249/PRO286
Study NCT01761955 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03386955 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02051088 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT02629185 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02629185 — Safety Biomarker (SAF): Interleukin 1
Study NCT03300323 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01703286 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00984802 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03403491 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01132573 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT00633828 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00113802 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01096771 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT02887209 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00849433 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02073110 — Predictive Biomarker (PRD): SRM mRNA
Genes: SRM; SPS1; SRML1
Study NCT01613469 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02623790 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03508375 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study NCT04158505 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00850707 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00850707 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00850707 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT00850707 — Predictive Biomarker (PRD): FCGR2B
Genes: CD32; CD32B; FcgammaRIIb; FcGRIIB
Study NCT00850707 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT03758833 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT03650933 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02598648 — Predictive Biomarker (PRD): RIPK3 mRNA
Genes: RIPK3; RIP3
Study NCT00223366 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT00223366 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT00472550 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT03221907 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02906579 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04395859 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02166437 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04665310 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT03635853 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01428505 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT01579539 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT03558685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01175070 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01175070 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01565083 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01742416 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00392756 — Predictive Biomarker (PRD): IHH mRNA
Genes: IHH
Study NCT03175744 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04603677 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04323397 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study NCT02756819 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04084587 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00097526 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00683358 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00683358 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00683358 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03827837 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04620655 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT04352374 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03811379 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00788957 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03847038 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03847038 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03833180 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT02860481 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05024461 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01273610 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01273610 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04013581 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01988012 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01301079 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04110587 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03328130 — Predictive Biomarker (PRD): PDE6B mRNA
Genes: PDE6B; PDEB
Study NCT04429451 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00479115 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00479115 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04109456 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT03873194 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01514877 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05395533 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00542685 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02788929 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03878342 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03233776 — Safety Biomarker (SAF): Interleukin 1
Study NCT04047641 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00462722 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03092453 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04724551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04724551 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT00171132 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03054688 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00108732 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03416478 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03466320 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT00862290 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT04212793 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04212793 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04622462 — Predictive Biomarker (PRD): S100A7 mRNA
Genes: S100A7; PSOR1; S100A7C
Study NCT03307304 — Predictive Biomarker (PRD): CLN3 mRNA
Genes: CLN3; BTS
Study NCT01342692 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03891355 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03941405 — Surrogate Endpoint (SUR): Serum sodium
Study NCT03941405 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02494856 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01505231 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT04035525 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT03069079 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06350474 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04268550 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT00463203 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02643901 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00331630 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00331630 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03801629 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT04239352 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study NCT04239352 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT02135159 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03332771 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03262298 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02598271 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03993873 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03993873 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT03993873 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT01073410 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT01073410 — Predictive Biomarker (PRD): CHIT1 mRNA
Genes: CHIT1
Study NCT02437799 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00006363 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02514707 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00802555 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT03031236 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06138093 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00888901 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT03956056 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02440620 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04272359 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04272359 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04582201 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00021645 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00021645 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03898843 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01852370 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03542097 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03703050 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02459704 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT01266005 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03436563 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03436563 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04253561 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04253561 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04462770 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study NCT01069835 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00423670 — Predictive Biomarker (PRD): BOC mRNA
Genes: BOC; UNQ604/PRO1190
Study NCT03193671 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT03193671 — Predictive Biomarker (PRD): WAP four-disulfide core domain protein 2
Genes: WFDC2; HE4; WAP5
Study NCT00426998 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01563627 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01563627 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02548663 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04023565 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05782920 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02787681 — Predictive Biomarker (PRD): IKBKG mRNA
Genes: IKBKG; FIP3; NEMO
Study NCT00939588 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04325867 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00784589 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05034380 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03238235 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT01737450 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01712386 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01669096 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01669096 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT01669096 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03923738 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT03923738 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04050085 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study NCT03953599 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01079507 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01704391 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01095757 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00005033 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02295774 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT02039336 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00750880 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00573248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00624481 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02674373 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02674373 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01904032 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03762681 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02303197 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03093857 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT03093857 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT01296360 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02030561 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02736227 — Predictive Biomarker (PRD): EVL mRNA
Genes: EVL; RNB6
Study NCT01199731 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT04203381 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00005928 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00005928 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03517618 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01660308 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00178360 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01509508 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00092040 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00943293 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00001338 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03808558 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03751683 — Predictive Biomarker (PRD): AIRE mRNA
Genes: AIRE; APECED
Study NCT02978898 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CD180 mRNA
Genes: CD180; LY64; RP105
Study NCT00949260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03992430 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03992430 — Surrogate Endpoint (SUR): Skeletal muscle dystrophin
Study NCT03086005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03086005 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03086005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03086005 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03614338 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01495390 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS